A Study on Pharmacokinetics of Compound Capsule of Paclitaxel in Rats
Sun Fang-di
Abstract
Sun Fang-di
Abstract
Objective To study the pharmacokinetics of compound capsules of paclitaxel in rats.Methods With the commercial Taxol as the reference preparation,a pharmacokinetic study of compound capsules of paclitaxel was performed in rats.Results The pharmacokinetic parameters were as follows:t1/2 was(51.681±7.188) min and(310.076±43.086) min.AUC was(496.719±64.036) μg·min/ml and(257.385±42.385) μg·min/ml,respectively.Conclusion Compound capsules of paclitaxel can elongate the retention time of paclitaxel in rats.The absolute bioavailability of paclitaxel is 25.9% for oral administration.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the pharmacokinetics of compound capsules of paclitaxel in rats.Methods With the commercial Taxol as the reference preparation,a pharmacokinetic study of compound capsules of paclitaxel was performed in rats.Results The pharmacokinetic parameters were as follows:t1/2 was(51.681±7.188) min and(310.076±43.086) min.AUC was(496.719±64.036) μg·min/ml and(257.385±42.385) μg·min/ml,respectively.Conclusion Compound capsules of paclitaxel can elongate the retention time of paclitaxel in rats.The absolute bioavailability of paclitaxel is 25.9% for oral administration.
Key concepts: Paclitaxel, Pharmacokinetics, Capsule, Bioavailability, Pharmacology, Chemistry, Medicine, Chemotherapy